{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:26:12Z","timestamp":1773278772866,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12,15]]},"DOI":"10.1093\/hmg\/ddq420","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T00:37:04Z","timestamp":1285720624000},"page":"4871-4885","source":"Crossref","is-referenced-by-count":42,"title":["Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy"],"prefix":"10.1093","volume":"19","author":[{"given":"Vinicia Assunta","family":"Polito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Abbondante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman S.","family":"Polishchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Nusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Salvia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,9,27]]},"reference":[{"key":"key\n\t\t\t\t20170522143316_DDQ420C1","first-page":"3421","article-title":"The mucopolysaccharidoses","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"Neufeld","year":"2001"},{"key":"key\n\t\t\t\t20170522143316_DDQ420C2","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM197010152831606","article-title":"The relative frequency of the Hurler and Hunter syndromes","volume":"283","author":"McKusick","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522143316_DDQ420C5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00569230","article-title":"Incidence of Hunter's syndrome","volume":"60","author":"Young","year":"1982","journal-title":"Hum. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/humu.1380020603","article-title":"Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene","volume":"2","author":"Hopwood","year":"1993","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1005335624386","article-title":"Molecular analysis in 23 Hunter disease families","volume":"20","author":"Lissens","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/hmg\/6.3.479","article-title":"Molecular and phenotypic variation in patients with severe Hunter syndrome","volume":"6","author":"Timms","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/adc.79.3.237","article-title":"Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease)","volume":"79","author":"Vafiadaki","year":"1998","journal-title":"Arch. Dis. Child."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF00194643","article-title":"Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome","volume":"86","author":"Wilson","year":"1991","journal-title":"Hum. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of Hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta. Paediatr. Suppl."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajhg.2009.07.011","article-title":"IDS crossing of the blood\u2013brain barrier corrects CNS defects in MPSII mice","volume":"85","author":"Polito","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2\u20135 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522143316_DDQ420C17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1542\/peds.2004-1023","article-title":"Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522143316_DDQ420C22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C23","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1515\/JPEM.2009.22.12.1159","article-title":"Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy","volume":"22","author":"Tanzer","year":"2009","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10545-007-0632-9","article-title":"The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann\u2013Pick disease","volume":"30","author":"Schuchman","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddh220","article-title":"Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study","volume":"13","author":"Roces","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C26","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522143316_DDQ420C27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C31","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/hmg\/ddn237","article-title":"Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in alpha-mannosidosis mice","volume":"17","author":"Blanz","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0167-4838(82)90213-8","article-title":"Multiple forms of iduronate 2-sulphate sulphatase in human tissues and body fluids","volume":"708","author":"Archer","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170522143316_DDQ420C33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/BJ20040739","article-title":"Analysis of normal and mutant iduronate-2-sulphatase conformation","volume":"386","author":"Parkinson-Lawrence","year":"2005","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ymthe.2005.02.031","article-title":"Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice","volume":"12","author":"Orii","year":"2005","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cvr\/cvm110","article-title":"PARP1 is required for adhesion molecule expression in atherogenesis","volume":"78","author":"von Lukowicz","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj3380687","article-title":"Phagocytosis stimulates alternative glycosylation of macrosialin (mouse CD68), a macrophage-specific endosomal protein","volume":"338","author":"da Silva","year":"1999","journal-title":"Biochem. J."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C38","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"key\n\t\t\t\t20170522143316_DDQ420C39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1012283426530","article-title":"Open-field behavior of house mice selectively bred for high voluntary wheel-running","volume":"31","author":"Bronikowski","year":"2001","journal-title":"Behav. Genet."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/19\/24\/4871\/17250167\/ddq420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T06:35:15Z","timestamp":1591943715000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddq420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,27]]},"references-count":39,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2010,9,27]]},"published-print":{"date-parts":[[2010,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddq420","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,27]]}}}